Atherosclerosis
Volume 209, Issue 1 , Pages 58-65 , March 2010

Cellular factors involved in CXCL8 expression induced by glycated serum albumin in vascular smooth muscle cells

  • Kyung-Ha Choi

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Jae-woo Park

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Hye-Young Kim

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Young-Hee Kim

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Sun-Mi Kim

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Yong-Hae Son

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Young-Chul Park

      Affiliations

    • Department of Microbiology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • ,
  • Seong-Kug Eo

      Affiliations

    • Laboratory of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Jeonju, Republic of Korea
    • ,
  • Koanhoi Kim

      Affiliations

    • Department of Pharmacology, School of Medicine–Pusan National University, Yangsan, Republic of Korea
    • Corresponding Author InformationCorresponding author at: Department of Pharmacology, School of Medicine and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea. Tel.: +82 51 510 8064; fax: +82 51 510 8068.

Received 11 May 2009 ,Revised 30 July 2009 ,Accepted 16 August 2009.

References 

  1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820
  2. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–146
  3. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science (New York, N.Y.). 1978;200:21–27
  4. Higgins PJ, Bunn HF. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. The Journal of Biological Chemistry. 1981;256:5204–5208
  5. Cohen MP, Clements RS, Cohen JA, Shearman CW. Glycated albumin promotes a generalized vasculopathy in the db/db mouse. Biochemical and Biophysical Research Communications. 1996;218:72–75
  6. Clements RS, Robison WG, Cohen MP. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. Journal of Diabetes and its Complications. 1998;12:28–33
  7. Ahmed N. Advanced glycation endproducts–role in pathology of diabetic complications. Diabetes Research and Clinical Practice. 2005;67:3–21
  8. Hattori Y, Kakishita H, Akimoto K, Matsumura M, Kasai K. Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. Biochemical and Biophysical Research Communications. 2001;281:891–896
  9. Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 2002;39:22–28
  10. Dragomir E, Manduteanu I, Calin M, et al. High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells. Thrombosis and Haemostasis. 2008;100:1155–1165
  11. Higai K, Shimamura A, Matsumoto K. Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2006;367:137–143
  12. Salazar R, Brandt R, Krantz S. Expression of fructosyllysine receptors on human monocytes and monocyte-like cell lines. Biochimica et Biophysica Acta. 1995;1266:57–63
  13. Wu VY, Cohen MP. Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells. Biochemical and Biophysical Research Communications. 1995;207:521–528
  14. Wu VY, Shearman CW, Cohen MP. Identification of calnexin as a binding protein for Amadori-modified glycated albumin. Biochemical and Biophysical Research Communications. 2001;284:602–606
  15. Ross R. The pathogenesis of atherosclerosis—an update. The New England Journal of Medicine. 1986;314:488–500
  16. Medzhitov R. Toll-like receptors and innate immunity. Nature Reviews. 2001;1:135–145
  17. Zuany-Amorim C, Hastewell J, Walker C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nature Reviews Drug Discovery. 2002;1:797–807
  18. Yang X, Coriolan D, Murthy V, et al. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient toll-like receptor 4 signaling. American Journal of Physiology. 2005;289:H1069–H1076
  19. Yang X, Murthy V, Schultz K, et al. Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. American Journal of Physiology. 2006;291:H2334–H2343
  20. Hong TJ, Ban JE, Choi KH, et al. TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells. Vascular Pharmacology. 2009;50:34–39
  21. Herder C, Haastert B, Muller-Scholze S, et al. Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes. 2005;54(Suppl. 2):S11–S17
  22. Wu YM, Robinson DR, Kung HJ. Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. Cancer Research. 2004;64:7311–7320
  23. Son YH, Jeong YT, Lee KA, et al. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 2008;51:71–77
  24. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1897–1908
  25. Brandt R, Krantz S. Glycated albumin (Amadori product) induces activation of MAP kinases in monocyte-like MonoMac 6 cells. Biochimica et Biophysica Acta. 2006;1760:1749–1753
  26. Bian ZM, Elner VM, Yoshida A, Kunkel SL, Elner SG. Signaling pathways for glycated human serum albumin-induced IL-8 and MCP-1 secretion in human RPE cells. Investigative Ophthalmology & Visual Science. 2001;42:1660–1668
  27. Hattori Y, Banba N, Gross SS, Kasai K. Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase. Biochemical and Biophysical Research Communications. 1999;259:128–132
  28. Jijon HB, Panenka WJ, Madsen KL, Parsons HG. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. American Journal of Physiology - Cell Physiology. 2002;283:C31–C41
  29. Winzen R, Kracht M, Ritter B, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. The EMBO Journal. 1999;18:4969–4980
  30. Jung YD, Fan F, McConkey DJ, et al. Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells. Cytokine. 2002;18:206–213
  31. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science (New York, N.Y.). 2003;301:640–643
  32. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. The Journal of Biological Chemistry. 1995;270:24995–25000
  33. Youn HS, Saitoh SI, Miyake K, Hwang DH. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochemical Pharmacology. 2006;72:62–69
  34. Youn HS, Lee JY, Fitzgerald KA, et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. Journal of Immunology. 2005;175:3339–3346
  35. Sun HN, Kim SU, Lee MS, et al. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent activation of phosphoinositide 3-kinase and p38 mitogen-activated protein kinase signal pathways is required for lipopolysaccharide-induced microglial phagocytosis. Biological & Pharmaceutical Bulletin. 2008;31:1711–1715
  36. Sumbayev VV. PI3 kinase and direct S-nitrosation are involved in down-regulation of apoptosis signal-regulating kinase 1 during LPS-induced Toll-like receptor 4 signalling. Immunology Letters. 2008;115:126–130
  37. Zeiffer U, Schober A, Lietz M, et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circulation Research. 2004;94:776–784
  38. Huo Y, Weber C, Forlow SB, et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. The Journal of Clinical Investigation. 2001;108:1307–1314
  39. Inoue T, Komoda H, Nonaka M, et al. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. International Journal of Cardiology. 2008;124:319–325

PII: S0021-9150(09)00693-5

doi: 10.1016/j.atherosclerosis.2009.08.030

Atherosclerosis
Volume 209, Issue 1 , Pages 58-65 , March 2010

Article Tools

* Image Usage & Resolution